Co-morbidity and use of medicines during the terminal stage of life in patients with COPD
Sven-Arne Jansson, Britt-Marie Sundblad, Lennarth Nyström, Peter Arvidsson, Bo Lundbäck, Kjell Larsson
European Respiratory Journal 2013 42: P3451; DOI:
Sven-Arne Jansson
1Lung and Allergy Research, The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Britt-Marie Sundblad
1Lung and Allergy Research, The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Lennarth Nyström
2Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
Peter Arvidsson
3GlaxoSmithKline (at the Time for the Study), Asthma/COPD, Stockholm, Sweden
Bo Lundbäck
4Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Kjell Larsson
1Lung and Allergy Research, The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Vol 42 Issue Suppl 57
Table of Contents
Co-morbidity and use of medicines during the terminal stage of life in patients with COPD
Sven-Arne Jansson, Britt-Marie Sundblad, Lennarth Nyström, Peter Arvidsson, Bo Lundbäck, Kjell Larsson
European Respiratory Journal Sep 2013, 42 (Suppl 57) P3451;